System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Laurent Misery

Dermatology — Centre Hospitalier Régional Universitaire de Brest, France

LeadR Profile

Laurent Misery Centre Hospitalier Régional Universitaire de Brest France
3 494 ScienceLeadR Reputation 3494

Unlock

Register Login
Network Map

Dermatology

Subspecialties: Immunology - Public Health - Infectiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Organizations

Source: Pubmed

Centre Hospitalier Régional Universitaire de Brest

Publications Synthesis

Source: Pubmed

Number : 1177

Citations

Citations: 21 748 1st author: 153 Last author: 318 Unique author: 88

Main journals

Ann Dermatol Venereol 326
J Eur Acad Dermatol Venereol 116
Acta Derm Venereol 65
Br J Dermatol 55
Annales de dermatologie et de vénéréologie, FMC 50

Best Journals

N Engl J Med 3
BMJ 1

Breakdown by type

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Drugs associated with generalized non-allergic pruritus: A World Health Organization pharmacovigilance database analysis.
vaccines, pharmaceutical preparations, pruritus, therapeutics, pharmacovigilance, dermatology		J Am Acad Dermatol20260
More than a symptom: itch as an independent clinical contributor in atopic dermatitis - a global-scale study on 15,223 patients.
syphilis, dermatitis, dermatology, dermatitis, atopic		Br J Dermatol20260
Chronic pruritus treated with alendronate in bilateral striopallidodentate calcinosis associated with an SLC20A2 gene mutation.
genes, skin diseases, alendronate, pruritus, calcinosis, mutation		J Dtsch Dermatol Ges20260
Real-World Burden of Generalized Pustular Psoriasis in a French Observational Study: Prevalence, Incidence, Healthcare Resource Utilization, Comorbidities, Treatment Use, and Mortality.
comorbidity, mortality, incidence, prevalence, therapeutics, psoriasis, steroids		Dermatol Ther (Heidelb)20260
Association of pruritus with comorbidities and survival in chronic kidney disease: a narrative review of the pre-difelikefalin era literature.
kidney diseases, comorbidity, health care costs, mortality, sleep, kidney, signs and symptoms, pruritus, therapeutics, acute kidney injury		Ren Fail20260

Clinical Studies 25

Source: ClinicalTrials

Synthesis

Principal Investigator: 4

By phase:

N/A 12
Phase 3 9
Phase 2 4

By status:

Completed 13
Recruiting 6
Not yet recruiting 3
Active not recruiting 1
Terminated 1
Unknown 1

By type:

Interventional 16
Observational 9

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 1
multicentric5to9 3
multicentricup10 14

Main Topics

Skin and Connective Tissue Diseases 11
Hemic and Lymphatic Diseases 4
Immune System Diseases 3
Congenital, Hereditary, and Neonatal Diseases and Abnormalities 2
Nervous System Diseases 2

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Study of Alloknesia in Atopic Dermatitis
NCT06923202 — touch, dermatitis, skin diseases, pruritus, dermatitis, atopic		N/ARecruiting2026
Efficacy and Tolerance of Cannabidiol in Patients with Severe Pruritus a Multicenter Double blind Randomized Placebo controlled Study
NCT06435299 — dronabinol, skin, pain, neurogenic inflammation, pruritus, therapeutics, antipruritics, cannabinoids, cannabidiol		Phase 3Not yet recruiting2025
Establishment of a Patient Library in Patients With Pruritus Sine Materia
NCT05678309 — depression, skin, quality of life, blood, serum, biopsy, pruritus, short interspersed nucleotide elements, dna, dermatology, plasma, rna		N/ANot yet recruiting2023
Constitution of a Prospective Cohort of Patients With Acute Suppurative Hidrosadenitis Followed in the Great West the COVER Cohort (Verneuil Cohort)
NCT04352036 — phenotype, hidradenitis		N/ARecruiting2022
A Long term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)
NCT04204616 — injections, safety, prurigo		Phase 3Active not recruiting2021

LeadR Networks

Main global connection map

Source: Pubmed Source: ClinicalTrials